Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 327NIH 68NETWORK 26OTHER_GOV 9INDUSTRY 8UNKNOWN 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Rectal Neoplasms 2Breast Neoplasms 1

Interventions

Paclitaxel 20Capecitabine 18S 1 (combination) 17Cisplatin 15Oxaliplatin 11Radiotherapy, Intensity-Modulated 9apatinib 8Epirubicin 8Docetaxel 8Carboplatin 8Radiotherapy 7Irinotecan 7titanium silicide 6sintilimab 6pyrotinib 6nimotuzumab 6anlotinib 6Drug Therapy 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6nedaplatin 5camrelizumab 5Temozolomide 5Etoposide 5Bevacizumab 5nabiximols 4Vinorelbine 4Trastuzumab 4Radiation Dose Hypofractionation 4Pemetrexed 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × Neoadjuvant Therapy × Clear all
NCT05484024 2022-08-02

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

ChineseAMS

Phase 2/3 Not yet recruiting
588 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02533271 2021-07-16

STELLAR

ChineseAMS

Phase 3 Unknown
600 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02934828 2016-10-18

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

ChineseAMS

Phase 2 Unknown
230 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡